Invesaro

Stocks CMCO Financial statements

Financial statements

COLUMBUS MCKINNON CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data COLUMBUS MCKINNON CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue6378398768096509079361,0149631,193
Cost of revenue444554571526429591594639637834
Gross profit193285305283220316342375326359
Research and development10.513.613.511.312.415.420.926.223.921.4
General and administrative72.185.683.677.97610294.8107107178
Operating income23.768.369.489.842.373.897.810754.6-119
Interest expense1119.717.114.212.120.127.93832.461.1
Other non-operating income2.342.470.72-0.84-20.91.122.07-7.6-25.81.53
Pre-tax income1349.752.977.210.138.474.561.5-5.51-207
Income tax4.0427.610.317.50.978.792614.9-0.3722.9
Net income to minority interests000.1
Net income8.9822.142.659.79.1129.748.446.6-5.14-230
EBITDA48.910410211970.4116140153103-42.3
EPS, basic0.440.971.832.530.381.061.691.62-0.18-7.40
EPS, diluted0.430.951.802.500.381.041.681.61-0.18-7.40
Shares, basic (weighted)20.622.823.323.623.92828.628.728.728.7
Shares, diluted (weighted)20.923.323.723.924.228.428.82928.728.7
Dividend per share0.160.170.210.240.240.250.280.280.280.28

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents77.66371.111420211513311453.796.6
Receivables112128129124105148151171165380
Inventory131153146127111172179186199609
Other current assets21.116.616.117.222.831.532.342.84895.1
Total current assets3413603633834424674965144661,181
Property, plant and equipment11311387.379.574.897.994.4106106409
Lease right-of-use assets35.638.134.230.853.665.659.588.4
Goodwill3193473233203316496457107111,409
Intangible assets2562642332182133913633863571,610
Long-term investments7.697.677.037.327.9710.310.411.410.110.2
Other non-current assets14.817.821.259.861.368.988.396.286.5165
Total assets1,1141,1421,0621,0931,1501,6861,6981,8261,7394,785
Accounts payable41474757.368.690.976.783.193.3169
Accrued liabilities97.410099.393.6111118124128114249
Deferred revenue15.911.510.815.422.52716.615.625
Short-term debt52.660.1654.454.4540.6405050166
Total current liabilities191207211155184250242262258584
Long-term debt3693032352472454574184674092,227
Lease liabilities031.627.323.746.560.759.764.2
Other non-current liabilities213224184228192193192203179525
Total liabilities7727346306306209138659448573,336
Total debt4213633002512494974585174592,393
Paid-in capital259269278287296506516527532541
Retained earnings180198236290294316357395382136
Treasury stock0-1.01-1-11-11
Other comprehensive income-97.5-59.3-83.1-114-60-49.9-38-39.7-21.1-6.75
Shareholders' equity5307738348828821,449
Minority interests0-0.1
Total equity3414084314645307738348828821,449
Total liabilities and equity1,1141,1421,0621,0931,1501,6861,6981,8261,7394,785
Shares outstanding22.62323.423.82428.528.628.828.628.7

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income8.9822.142.659.79.1129.748.446.6-5.14-229
Depreciation and amortization25.236.132.729.128.241.941.945.948.277
Stock-based compensation5.915.596.24.518.0211.210.4126.269.57
Deferred income tax0.4920-0.967.36-8.7-1.97-0.3-15.3-20.3-10.7
Change in receivables0.79-9.31-11.32.921.5-19-4.86-14.44.48-10.7
Change in inventory-8.17-12.2-15.415.820.7-40.2-9.09-1.31-1315.3
Cash from operations60.569.779.510798.948.983.667.245.6-146
Capital expenditures-14.4-14.5-12.3-9.43-12.3-13.1-12.6-24.8-21.4-17.9
Acquisitions-21900-540-1.62-1080-2,627
Purchases of investments-4.95-7.13-4.02-4.08-3.68-3.17
Sales and maturities of investments65.114.433.653.535.063.54
Cash from investing-224-32.62.49-9.96-5.55-554-13.9-133-19.9-2,458
Debt issued00725012002,590
Stock issued50.46.334.1561.972.660.711.60.370.03
Share buybacks0000-10-100
Dividends paid-3.42-3.9-4.9-5.69-5.75-7.12-8.01-8.04-8.04-8.04
Cash from financing191-59.5-67.8-51.6-10.2421-5048.2-86.72,653
Exchange rate effect-0.547.57-6.43-1.934.52-2.01-1.93-1.090.58-6.46
Net change in cash26-14.97.7843.487.7-86.717.8-19.1-60.443.1
Free cash flow46.155.167.297.486.635.87142.424.2-164
Interest paid10.618.914.411.69.4518.826.13530.145.6
Income taxes paid1.890.714.8411.610.29.772228.420.545.9

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $16.83 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin28.8%Gross profit / revenue.
Operating margin-9.6%Operating income / revenue.
EBITDA margin-1.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-18.3%Pre-tax income / revenue.
Net margin-21.2%Net income / revenue.
FCF margin-8.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-6.9%Cash from operations / revenue.
Return on equity (ROE)-23.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-6.8%Net income / average total assets.
Return on invested capital (ROIC)-3.1%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue1.7%Research and development expense / revenue.
Stock-based pay / revenue0.7%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.4%Capital expenditures / revenue.
D&A / revenue7.9%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y23.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y8.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y12.9%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y10.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y1.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y10.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-318.7%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y-141.2%EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y-420.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y-777.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y0.0%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y3.1%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y64.2%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y20.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y22.3%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y175.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y41.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y33.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y3.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.00xCurrent assets / current liabilities.
Quick ratio0.84x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.18x(Cash + short-term investments) / current liabilities.
Debt / equity1.74xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets50.8%Total debt / total assets.
Liabilities / assets70.8%Total liabilities / total assets.
Net debt$2.28BTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-1.42xOperating income / interest expense.
Working capital$560.6MCurrent assets - current liabilities.
Goodwill and intangibles / assets63.9%(Goodwill + intangible assets) / total assets.
Tangible book value-$1.62BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.32xRevenue / average total assets.
Fixed asset turnover3.80xRevenue / average property, plant and equipment.
Inventory turnover1.90xCost of revenue / average inventory.
Days inventory192 days365 x average inventory / cost of revenue.
Receivables turnover3.99xRevenue / average receivables.
Days sales outstanding91 days365 x average receivables / revenue.
Days payables55 days365 x average accounts payable / cost of revenue.
Cash conversion cycle229 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$10.99Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$51.71Revenue / diluted weighted shares.
FCF per share-$4.26Free cash flow / diluted weighted shares.
Operating cash flow per share-$3.56Cash from operations / diluted weighted shares.
Book value per share$47.41Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$56.15Tangible book value / shares outstanding.
Cash per share$3.41(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$485.8MShare price x shares outstanding.
Enterprise value$2.76BMarket cap + total debt - cash - short-term investments.
P/S0.33xMarket cap / revenue.
P/B0.36xMarket cap / shareholders' equity. Only when equity is positive.
EV/Sales1.86xEnterprise value / revenue.
FCF yield-25.3%Free cash flow / market cap.
Earnings yield-65.1%Net income / market cap (the inverse of P/E).
Dividend yield1.7%Dividends paid over the period / market cap.
Shareholder yield1.7%(Dividends paid + share buybacks) / market cap.
What was COLUMBUS MCKINNON CORP's revenue in fiscal 2026?

COLUMBUS MCKINNON CORP reported revenue of $1.19B for fiscal 2026, 23.9% higher than the year before.

Was COLUMBUS MCKINNON CORP profitable in fiscal 2026?

No. It reported a net loss of $229.5M.

How much free cash flow did COLUMBUS MCKINNON CORP generate in fiscal 2026?

Cash from operations of $146.2M minus capital expenditures of $17.9M left free cash flow of -$164.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to COLUMBUS MCKINNON CORP